The deep brain stimulation device market size has grown rapidly in recent years. It will grow from $1.7 billion in 2025 to $1.9 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, wider clinical acceptance of deep brain stimulation, expansion of neurosurgical specialty centers, improved safety profiles of implantable devices, availability of advanced neuroimaging technologies.
The deep brain stimulation device market size is expected to see rapid growth in the next few years. It will grow to $2.94 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to growing focus on precision neuromodulation therapies, rising investments in neurotechnology research, expansion of indications beyond movement disorders, increasing adoption of remote programming capabilities, continuous innovation in implantable electronics. Major trends in the forecast period include increasing adoption of closed-loop neurostimulation systems, rising demand for personalized dbs programming, growing use of rechargeable implantable pulse generators, expansion of image-guided electrode placement techniques, enhanced focus on minimally invasive neurosurgical procedures.
The anticipated growth in the deep brain stimulation (DBS) device market is expected to be propelled by the increasing prevalence of neurological diseases. Neurological disorders, affecting the central and peripheral nervous systems, can be effectively addressed by DBS devices, which are designed to regulate abnormal brain activity and rectify chemical imbalances contributing to various conditions. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, with projections indicating this could rise to 13.8 million by 2060. This surge in neurological disorders is a significant driver behind the growth of the deep brain stimulation device market.
Leading companies in the deep brain stimulation device market are focusing on technological advancements, including connected care technology, to improve patient care by enabling remote programming, enhancing communication between patients and healthcare providers, and optimizing treatment outcomes for individuals with movement disorders. Connected care technology involves the integration of digital tools and platforms that promote continuous communication and data exchange between patients and healthcare providers, thereby enhancing patient monitoring, treatment management, and overall healthcare delivery. For example, in January 2024, Abbott Laboratories, a U.S.-based healthcare and medical device company, received approval from the U.S. Food and Drug Administration for the Liberta RC DBS system, which is the smallest rechargeable deep brain stimulation device designed for treating movement disorders. Key features of the Liberta RC DBS system include remote programming capabilities via the NeuroSphere Virtual Clinic, a requirement of only 10 recharges per year, and a compact design that is 31% smaller than competing devices. Additionally, it features a wireless charging system that can recharge the device every 37 days and offers customizable controls through an Abbott patient controller or compatible iOS devices.
In September 2023, Amber Therapeutics, a US-based healthcare technology company, acquired Bioinduction Limited for an undisclosed amount. Through this acquisition, Amber Therapeutics aims to strengthen its technological capabilities and speed the development of its closed-loop neuromodulation therapy for mixed urinary incontinence. Bioinduction Limited is a UK-based healthcare technology company that specializes in deep brain stimulation (DBS) devices.
Major companies operating in the deep brain stimulation device market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova plc, Aleva Neurotherapeutics SA, Beijing PINS Medical Co. Ltd., SceneRay Corporation, MicroPort NeuroTech, Precisis AG, Neuralink Corporation, Sapiens Neuro, Functional Neuromodulation Ltd., Deep Brain Innovation LLC, Renishaw plc, NeuroOne Medical Technologies Corporation, CorTec GmbH, INBRAIN Neuroelectronics S.L., Synchron Inc., Rune Labs Inc., CereGate GmbH.
North America was the largest region in the deep brain stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global deep brain stimulation devices market report during the forecast period. The regions covered in the deep brain stimulation device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the deep brain stimulation device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the deep brain stimulation device market by increasing costs of imported electronic components, microprocessors, medical-grade metals, and precision manufacturing equipment used in implantable pulse generators and electrode systems. North America and Europe are most affected due to reliance on cross-border sourcing of high-value components, while Asia-Pacific faces cost pressures on device exports. These tariffs are increasing overall device prices and procurement costs for hospitals. However, they are also encouraging localized manufacturing, regional supply chain diversification, and investment in domestic medical device production capabilities.
The deep brain stimulation device market research report is one of a series of new reports that provides deep brain stimulation device market statistics, including deep brain stimulation device industry global market size, regional shares, competitors with a deep brain stimulation device market share, detailed deep brain stimulation device market segments, market trends and opportunities, and any further data you may need to thrive in the deep brain stimulation device industry. This deep brain stimulation device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Deep brain stimulation (DBS) devices are specialized medical instruments designed to administer electrical currents directly to specific areas of the brain. These electrical impulses serve to address chemical imbalances within the brain that may contribute to various neuropsychological disorders. DBS is a therapeutic approach employed for the treatment of these conditions.
The primary product types within the category of deep brain stimulation devices are single-channel deep brain stimulators and dual-channel deep brain stimulators. A single-channel deep brain stimulator is a medical device specifically engineered to deliver electrical currents directly to targeted areas of the brain. These devices find application in addressing a range of conditions, including epilepsy, essential tremor, obsessive-compulsive disorder (OCD), depression, dystonia, Parkinson’s disease, and pain management. These devices are utilized in various healthcare settings such as hospitals, neurology clinics, ambulatory surgical centers, and research centers.
The deep brain stimulation devices market consists of sales of neurostimulators, leads, extensions, and handheld controllers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The deep brain stimulation device market size is expected to see rapid growth in the next few years. It will grow to $2.94 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to growing focus on precision neuromodulation therapies, rising investments in neurotechnology research, expansion of indications beyond movement disorders, increasing adoption of remote programming capabilities, continuous innovation in implantable electronics. Major trends in the forecast period include increasing adoption of closed-loop neurostimulation systems, rising demand for personalized dbs programming, growing use of rechargeable implantable pulse generators, expansion of image-guided electrode placement techniques, enhanced focus on minimally invasive neurosurgical procedures.
The anticipated growth in the deep brain stimulation (DBS) device market is expected to be propelled by the increasing prevalence of neurological diseases. Neurological disorders, affecting the central and peripheral nervous systems, can be effectively addressed by DBS devices, which are designed to regulate abnormal brain activity and rectify chemical imbalances contributing to various conditions. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, with projections indicating this could rise to 13.8 million by 2060. This surge in neurological disorders is a significant driver behind the growth of the deep brain stimulation device market.
Leading companies in the deep brain stimulation device market are focusing on technological advancements, including connected care technology, to improve patient care by enabling remote programming, enhancing communication between patients and healthcare providers, and optimizing treatment outcomes for individuals with movement disorders. Connected care technology involves the integration of digital tools and platforms that promote continuous communication and data exchange between patients and healthcare providers, thereby enhancing patient monitoring, treatment management, and overall healthcare delivery. For example, in January 2024, Abbott Laboratories, a U.S.-based healthcare and medical device company, received approval from the U.S. Food and Drug Administration for the Liberta RC DBS system, which is the smallest rechargeable deep brain stimulation device designed for treating movement disorders. Key features of the Liberta RC DBS system include remote programming capabilities via the NeuroSphere Virtual Clinic, a requirement of only 10 recharges per year, and a compact design that is 31% smaller than competing devices. Additionally, it features a wireless charging system that can recharge the device every 37 days and offers customizable controls through an Abbott patient controller or compatible iOS devices.
In September 2023, Amber Therapeutics, a US-based healthcare technology company, acquired Bioinduction Limited for an undisclosed amount. Through this acquisition, Amber Therapeutics aims to strengthen its technological capabilities and speed the development of its closed-loop neuromodulation therapy for mixed urinary incontinence. Bioinduction Limited is a UK-based healthcare technology company that specializes in deep brain stimulation (DBS) devices.
Major companies operating in the deep brain stimulation device market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova plc, Aleva Neurotherapeutics SA, Beijing PINS Medical Co. Ltd., SceneRay Corporation, MicroPort NeuroTech, Precisis AG, Neuralink Corporation, Sapiens Neuro, Functional Neuromodulation Ltd., Deep Brain Innovation LLC, Renishaw plc, NeuroOne Medical Technologies Corporation, CorTec GmbH, INBRAIN Neuroelectronics S.L., Synchron Inc., Rune Labs Inc., CereGate GmbH.
North America was the largest region in the deep brain stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global deep brain stimulation devices market report during the forecast period. The regions covered in the deep brain stimulation device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the deep brain stimulation device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the deep brain stimulation device market by increasing costs of imported electronic components, microprocessors, medical-grade metals, and precision manufacturing equipment used in implantable pulse generators and electrode systems. North America and Europe are most affected due to reliance on cross-border sourcing of high-value components, while Asia-Pacific faces cost pressures on device exports. These tariffs are increasing overall device prices and procurement costs for hospitals. However, they are also encouraging localized manufacturing, regional supply chain diversification, and investment in domestic medical device production capabilities.
The deep brain stimulation device market research report is one of a series of new reports that provides deep brain stimulation device market statistics, including deep brain stimulation device industry global market size, regional shares, competitors with a deep brain stimulation device market share, detailed deep brain stimulation device market segments, market trends and opportunities, and any further data you may need to thrive in the deep brain stimulation device industry. This deep brain stimulation device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Deep brain stimulation (DBS) devices are specialized medical instruments designed to administer electrical currents directly to specific areas of the brain. These electrical impulses serve to address chemical imbalances within the brain that may contribute to various neuropsychological disorders. DBS is a therapeutic approach employed for the treatment of these conditions.
The primary product types within the category of deep brain stimulation devices are single-channel deep brain stimulators and dual-channel deep brain stimulators. A single-channel deep brain stimulator is a medical device specifically engineered to deliver electrical currents directly to targeted areas of the brain. These devices find application in addressing a range of conditions, including epilepsy, essential tremor, obsessive-compulsive disorder (OCD), depression, dystonia, Parkinson’s disease, and pain management. These devices are utilized in various healthcare settings such as hospitals, neurology clinics, ambulatory surgical centers, and research centers.
The deep brain stimulation devices market consists of sales of neurostimulators, leads, extensions, and handheld controllers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Deep Brain Stimulation Device Market Characteristics
3. Deep Brain Stimulation Device Market Supply Chain Analysis
4. Global Deep Brain Stimulation Device Market Trends and Strategies
5. Deep Brain Stimulation Device Market Analysis of End Use Industries
7. Global Deep Brain Stimulation Device Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Deep Brain Stimulation Device Total Addressable Market (TAM) Analysis for the Market
9. Deep Brain Stimulation Device Market Segmentation
10. Deep Brain Stimulation Device Market Regional and Country Analysis
11. Asia-Pacific Deep Brain Stimulation Device Market
12. China Deep Brain Stimulation Device Market
13. India Deep Brain Stimulation Device Market
14. Japan Deep Brain Stimulation Device Market
15. Australia Deep Brain Stimulation Device Market
16. Indonesia Deep Brain Stimulation Device Market
17. South Korea Deep Brain Stimulation Device Market
18. Taiwan Deep Brain Stimulation Device Market
19. South East Asia Deep Brain Stimulation Device Market
20. Western Europe Deep Brain Stimulation Device Market
21. UK Deep Brain Stimulation Device Market
22. Germany Deep Brain Stimulation Device Market
23. France Deep Brain Stimulation Device Market
24. Italy Deep Brain Stimulation Device Market
25. Spain Deep Brain Stimulation Device Market
26. Eastern Europe Deep Brain Stimulation Device Market
27. Russia Deep Brain Stimulation Device Market
28. North America Deep Brain Stimulation Device Market
29. USA Deep Brain Stimulation Device Market
30. Canada Deep Brain Stimulation Device Market
31. South America Deep Brain Stimulation Device Market
32. Brazil Deep Brain Stimulation Device Market
33. Middle East Deep Brain Stimulation Device Market
34. Africa Deep Brain Stimulation Device Market
36. Deep Brain Stimulation Device Market Competitive Landscape and Company Profiles
37. Deep Brain Stimulation Device Market Other Major and Innovative Companies
40. Deep Brain Stimulation Device Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Deep Brain Stimulation Device Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses deep brain stimulation device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for deep brain stimulation device? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The deep brain stimulation device market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Single-Channel Deep Brain Stimulator; Dual-Channel Deep Brain Stimulator2) By Application: Epilepsy; Essential Tremor; Obsessive-Compulsive Disorder (OCD); Dystonia; Parkinson’s Disease; Other Applications
3) By End User: Hospitals; Neurology Clinics; Ambulatory Surgical Centers; Research Centers
Subsegments:
1) By Single-Channel Deep Brain Stimulator: Implantable Pulse Generators; Electrode Leads; Accessories2) By Dual-Channel Deep Brain Stimulator: Implantable Pulse Generators; Electrode Leads; Accessories
Companies Mentioned: Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; LivaNova plc; Aleva Neurotherapeutics SA; Beijing PINS Medical Co. Ltd.; SceneRay Corporation; MicroPort NeuroTech; Precisis AG; Neuralink Corporation; Sapiens Neuro; Functional Neuromodulation Ltd.; Deep Brain Innovation LLC; Renishaw plc; NeuroOne Medical Technologies Corporation; CorTec GmbH; INBRAIN Neuroelectronics S.L.; Synchron Inc.; Rune Labs Inc.; CereGate GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Deep Brain Stimulation Device market report include:- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- LivaNova plc
- Aleva Neurotherapeutics SA
- Beijing PINS Medical Co. Ltd.
- SceneRay Corporation
- MicroPort NeuroTech
- Precisis AG
- Neuralink Corporation
- Sapiens Neuro
- Functional Neuromodulation Ltd.
- Deep Brain Innovation LLC
- Renishaw plc
- NeuroOne Medical Technologies Corporation
- CorTec GmbH
- INBRAIN Neuroelectronics S.L.
- Synchron Inc.
- Rune Labs Inc.
- CereGate GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.9 Billion |
| Forecasted Market Value ( USD | $ 2.94 Billion |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
